litlas
ログインアカウント作成

C. Boni

1983–2018 年に発表

36
論文数
20,646
被引用数
36
h 指数
36
i10 指数

被引用数

C. Boni の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 2 件1992 年: 被引用 2 件1993 年: 被引用 3 件1994 年: 被引用 1 件1995 年: 被引用 6 件1996 年: 被引用 5 件1997 年: 被引用 1 件1998 年: 被引用 10 件1999 年: 被引用 22 件2000 年: 被引用 21 件2001 年: 被引用 35 件2002 年: 被引用 64 件2003 年: 被引用 91 件2004 年: 被引用 119 件2005 年: 被引用 158 件2006 年: 被引用 139 件2007 年: 被引用 165 件2008 年: 被引用 144 件2009 年: 被引用 150 件2010 年: 被引用 151 件2011 年: 被引用 166 件2012 年: 被引用 126 件2013 年: 被引用 160 件2014 年: 被引用 198 件2015 年: 被引用 182 件2016 年: 被引用 157 件2017 年: 被引用 166 件2018 年: 被引用 123 件2019 年: 被引用 461 件2020 年: 被引用 397 件2021 年: 被引用 346 件2022 年: 被引用 242 件2023 年: 被引用 148 件2024 年: 被引用 232 件2025 年: 被引用 98 件2026 年: 被引用 4 件1986〜1987 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,426 件、この内訳の 21.5%イタリア: 引用元論文 558 件、この内訳の 8.4%中国: 引用元論文 469 件、この内訳の 7.1%フランス: 引用元論文 426 件、この内訳の 6.4%イギリス: 引用元論文 421 件、この内訳の 6.4%ドイツ: 引用元論文 375 件、この内訳の 5.7%日本: 引用元論文 327 件、この内訳の 4.9%スペイン: 引用元論文 275 件、この内訳の 4.1%オランダ: 引用元論文 195 件、この内訳の 2.9%ベルギー: 引用元論文 176 件、この内訳の 2.7%カナダ: 引用元論文 174 件、この内訳の 2.6%韓国: 引用元論文 172 件、この内訳の 2.6%
0%21.5%その他 24.7%

機関

分野

  • Medicine77%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Immunology and Microbiology0.9%
  • Materials Science0.7%
  • Neuroscience0.5%
  • Engineering0.4%
  • その他1.8%

トピック

  • Colorectal Cancer Treatments and Studies11.2%
  • Colorectal Cancer Surgical Treatments6.3%
  • Gastric Cancer Management and Outcomes4.8%
  • Cancer Treatment and Pharmacology4.1%
  • Hepatocellular Carcinoma Treatment and Prognosis4%
  • Genetic factors in colorectal cancer3.1%
  • その他66.5%

共著者

全論文

検索で開く
  1. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

    著者: Thierry André, C. Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, C. Topham, Marta Zaninelli, Philip R. Clingan, John Bridgewater, Isabelle Tabah-Fisch, Aimery de Gramont - New England Journal of Medicine 2004 被引用: 3,658

  2. Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

    著者: Thierry André, C. Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, C. Topham, Andrea Bonetti, Philip R. Clingan, John Bridgewater, Fernando Rivera, Aimery de Gramont - Journal of Clinical Oncology 2009 被引用: 2,292

  3. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

    著者: Fotios Loupakis, Chiara Cremolini, Gianluca Masi, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Enrico Cortesi, Gianluca Tomasello, Monica Ronzoni, Rosella Spadi, Alberto Zaniboni, Giuseppe Tonini, Angela Buonadonna, D. Amoroso, Silvana Chiara, Chiara Carlomagno, C. Boni, Giacomo Allegrini, Luca Boni, Alfredo Falcone - New England Journal of Medicine 2014 被引用: 1,078

  4. Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

    著者: Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Marie-Laure Risse, Jaffer A. Ajani - Journal of Clinical Oncology 2006 被引用: 1,933

  5. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

    著者: Aimery de Gramont, Arié Figer, Michel Seymour, M. Homerin, Abdel Hmissi, Jim Cassidy, C. Boni, H. Cortés-Funes, Andrés Cervantes, Gilles Freyer, D. Papamichael, N Le Bail, Christophe Louvet, Daniel Hendler, Filippo de Braud, C. Wilson, F. Morvan, Andrea Bonetti - Journal of Clinical Oncology 2000 被引用: 3,820

  6. Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

    著者: Christophe Tournigand, Thierry André, Franck Bonnetain, Benoist Chibaudel, Gérard Lledo, Tamas Hickish, Josep Tabernero, C. Boni, Jean‐Baptiste Bachet, Luís Teixeira, Aimery de Gramont - Journal of Clinical Oncology 2012 被引用: 390

  7. Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

    著者: Gianluca Masi, Lisa Salvatore, Luca Boni, Fotios Loupakis, Chiara Cremolini, Lorenzo Fornaro, Marta Schirripa, S. Cupini, C. Barbara, V. Safina, Cristina Granetto, Elena Fea, Lorenzo Antonuzzo, C. Boni, Giacomo Allegrini, S. Chiara, D. Amoroso, Andrea Bonetti, Alfredo Falcone - Annals of Oncology 2015 被引用: 169

  8. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

    著者: Armando Santoro, Lorenza Rimassa, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean‐Luc Van Laethem, Hans Van Vlierberghe, Jörg Trojan, Frank T. Kolligs, Alan Weiss, Steven A. Miles, Antonio Gasbarrini, Monica Lencioni, Luca Cicalese, Morris Sherman, Cesare Gridelli, Peter Buggisch, Guido Gerken, Roland M. Schmid, C. Boni, Nicola Personeni, Ziad Hassoun, Giovanni Abbadessa, Brian Schwartz, Reinhard von Roemeling, Maria Lamar, Yinpu Chen, Camillo Porta - The Lancet Oncology 2012 被引用: 550

  9. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

    著者: Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi, Michele De Laurentiis, C. Boni, Giovanna Cavazzini, Antonio Durando, Anna Turletti, Cecilia Nisticò, Enrichetta Valle, Ornella Garrone, Fabio Puglisi, Filippo Montemurro, Sandro Barni, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Mario Giuliano, Adriano Gravina, Paola Papaldo, Claudia Bighin, Giancarlo Bisagni, Valeria Forestieri, Francesco Cognetti - The Lancet 2015 被引用: 201

  10. Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

    著者: Eric Van Cutsem, C. Boni, Josep Tabernero, Bartomeu Massutí, Gary Middleton, Faysal Dane, Peter Reichardt, Francisco Pimentel, Allen Lee Cohn, Philippe Follana, Michael Clemens, Alberto Zaniboni, Vladimir Moiseyenko, Mark Harrison, Donald Richards, Hans Prenen, Simon Pernot, Evelyne Ecstein-Fraïsse, Simon Hitier, P. Rougier - Annals of Oncology 2014 被引用: 133

  11. Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

    著者: Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, R. Pérez-Carrión, C. Boni, Alain Monnier, Justus Apffelstaedt, Robert E. Smith, H.P. Sleeboom, Fritz Jaenicke, A Płużańska, Magdolna Dank, D. Becquart, P. P. Bapsy, Eeva Salminen, Ray Snyder, Hilary A. Chaudri‐Ross, Raquel Lang, P.J. Wyld, Ajay S. Bhatnagar - Journal of Clinical Oncology 2003 被引用: 746

  12. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

    著者: Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, Giancarlo Bisagni, Grazia Arpino, Maria Giuseppa Sarobba, Ferdinando Riccardi, Antonio Russo, Lucia Del Mastro, Alessio Aligi Cogoni, Francesco Cognetti, Stefania Gori, Jennifer Foglietta, Antonio Frassoldati, D. Amoroso, Lucio Laudadio, Luca Moscetti, Filippo Montemurro, Claudio Verusio, Antônio Bernardo, Vito Lorusso, Adriano Gravina, Gabriella Moretti, Rossella Lauria, Antonella Lai, Carmela Mocerino, Sérgio Rizzo, Francesco Nuzzo, Paolo Carlini, Francesco Perrone, Antonello Accurso, Biagio Agostara, Michele Aieta, Oscar Alabiso, Maria Grazia Alicicco, Dino Amadori, Laura Amaducci, Gianna Amiconi, Giustino Antuzzi, Mara Ardine, Antonio Ardizzoia, Caterina Aversa, Giuseppe Badalamenti, Sandro Barni, Carlo Basurto, Rossana Berardi, Cinzia Bergamasco, Paolo Bidoli, Claudia Bighin, Edoardo Biondi, Giancarlo Bisagni, C. Boni, Karen Borgonovo, Mario Botta, Stefano Bravi, Paolo Bruzzi, Giuseppe Buono, Alfredo Butera, A. Caldara, Giampiero Candeloro, C. Cappelletti, Cinzia Cardalesi, E Carfora, Anna Cariello, Francesco Carrozza, Giacomo Cartenì, Michele Caruso, Virginia Casadei, Cláudia Casanova, L. Castori, Luigi Cavanna, Giovanna Cavazzini, Marina Elena Cazzaniga, Mario Giovanni Chilelli, Paolo Chiodini, Silvia Chiorrini, Fortunato Ciardiello, Mariangela Ciccarese, Saverio Cinieri, Mario Clerico, Mariarosa Coccaro, Mario Comandè, Claudia Corbo, G. Cortino, Stefania Cusenza, Gennaro Daniele, Alfonso Maria D’Arco, G. D'Auria, Claudio Dazzi, Carmine De Angelis, Filippo de Braud, Gianfranco De Feo, A. De Matteis, Michele De Tursi, Anna Di Blasio, Giuseppe Di Lucca, Liberato Di Lullo, Francesca Di Rella, Gianfranco Di Renzo, P. Di Stefano ほか 128 名 - The Lancet Oncology 2018 被引用: 88

  13. Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

    著者: Umberto Veronesi, G. De Palo, Ettore Marubini, Alfredo Costa, Franca Formelli, Luigi Mariani, Andrea DeCensi, Tiziana Camerini, Marco Rosselli Del Turco, Maria Gaetana Di Mauro, Maria Grazia Muraca, M. Del Vecchio, Carmine Pinto, Giuseppe D’Aiuto, C. Boni, Tiziana Campa, Andrea Magni, Rosalba Miceli, Marjorie Perloff, Winfred F. Malone, Michael B. Sporn - JNCI Journal of the National Cancer Institute 1999 被引用: 421

  14. Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

    著者: Valentina Guarneri, Antonio Frassoldati, Alberto Bottini, Katia Cagossi, Giancarlo Bisagni, Samanta Sarti, Alberto Ravaioli, Luigi Cavanna, Giovanni Giardina, Antonino Musolino, Michael Untch, Laura Orlando, Fabrizio Artioli, C. Boni, Daniele Generali, Patrizia Serra, M. Bagnalasta, Luca Marini, Federico Piacentini, Roberto D’Amico, PierFranco Conte - Journal of Clinical Oncology 2012 被引用: 368

  15. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

    著者: Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo, Roberto Labianca, Alfredo Falcone, Francesco Di Costanzo, G. Comella, D. Amadori, Carmine Pinto, Chiara Carlomagno, D. Nitti, Bruno Daniele, Enrico Mini, Davide Poli, Armando Santoro, Stefania Mosconi, R. Casaretti, C. Boni, G. Pinotti, Paolo Bidoli, Lorenza Landi, Gerardo Rosati, Alessandra Ravaioli, Maurizio Cantore, Francesca Di Fabio, Enrico Aitini, Alberto Marchet, Irene Floriani, Eliana Rulli, M. Cropalato Di Tullio, Davide Poli, Francesca Galli, Elena Biagioli, Irene De Simone, Davide Poli, S. Mangano, Maurizio Tonato, Emanuele Zucca, Maria Grazia Valsecchi, Irene Floriani, Emilio Bajetta, Maria Di Bartolomeo, Roberto Labianca, D. Amadori, Alfredo Falcone, Francesco Di Costanzo, Bruno Daniele, Carmine Pinto, G. Comella, D. Nitti, Enrico Mini, Sabino De Placido, Alberto Marchet, Emilio Bajetta, Maria Di Bartolomeo, L. Catena, Massimo Schiavo, G. Pinotti, Ilaria Proserpio, Gerardo Rosati, Roberto Bordonaro, S. Cordio, Giovanni Burrafato, Anna Maria Bochicchio, Michele Aieta, Nicola Fazio, Fabio Spada, Vito Amoroso, G Marini, Héctor Soto Parrà, G. Novello, B. Massidda, Maria Teresa Ionta, Mario Comandè, R Venezia, A. Bertolini, E. Menatti, L. Zanlorenzi, Alberto Colombo, A. Iop, Salvatore Bonura, Elena Mazza, Maria Grazia Viganò, A. Ardizzoia, Stefania Dell’Oro, Re G, Davide Adriano Santeufemia, Angela Buonadonna, Dimitri Luisi, G. Ucci, Giuseppe Di Lucca, Andrea Bonetti, Francesca Bergamo, Massimiliano Alù, Francesca Vastola, Paolo Marchetti, D.C. Corsi, Elena Massa, Carmine Pinto, Mary Duro ほか 122 名 - Annals of Oncology 2014 被引用: 90

  16. Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

    著者: Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, R. Pérez-Carrión, C. Boni, Alain Monnier, Justus Apffelstaedt, Robert E. Smith, H.P. Sleeboom, F. Jänicke, A Płużańska, Magdolna Dank, D. Becquart, P. P. Bapsy, Eeva Salminen, Ray Snyder, M. Lassus, J. Arnold Verbeek, Beatrix Staffler, Hilary A. Chaudri‐Ross, Margaret Dugan - Journal of Clinical Oncology 2001 被引用: 1,016

  17. Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

    著者: Carmelo Bengala, Federica Bertolini, N. Malavasi, C. Boni, Enrico Aitini, Cristina Dealis, S. Zironi, Roberta Depenni, Annalisa Fontana, Cinzia Del Giovane, Gabriele Luppi, PierFranco Conte - British Journal of Cancer 2009 被引用: 215

  18. Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

    著者: Tiziana Pressiani, C. Boni, Lorenza Rimassa, Roberto Labianca, S. Fagiuoli, Stefania Salvagni, Dora Ferrari, Enrico Cortesi, Camillo Porta, Claudia Mucciarini, Luciano Latini, Carlo Carnaghi, Maria Banzi, Silvia Fanello, Massimo De Giorgio, Romano Fabio Lutman, G. Torzilli, Maurizio Tommasini, Roberto Ceriani, Giovanni Covini, Maria Chiara Tronconi, Laura Giordano, N. Locopo, S. Naimo, Armando Santoro - Annals of Oncology 2012 被引用: 152

  19. Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

    著者: Sergio Bracarda, Roberto Iacovelli, Luca Boni, Mimma Rizzo, Lisa Derosa, Marta Rossi, Luca Galli, Giuseppe Procopio, Michele Sisani, Flavia Longo, Matteo Santoni, Franco Morelli, Giuseppe Di Lorenzo, Amelia Altavilla, Camillo Porta, Andrea Camerini, Bernard Escudier, Angelo Martignetti, Riccardo Ricotta, Donatello Gasparro, Roberto Sabbatini, Giovanni Luca Ceresoli, Alessandra Mosca, Daniele Santini, Claudia Caserta, Luigi Cavanna, Francesco Massari, Teodoro Sava, C. Boni, Elena Verzoni, Giacomo Cartenì, Alketa Hamzaj - Annals of Oncology 2015 被引用: 105

  20. Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

    著者: Giorgio V. Scagliotti, Filippo de Marinis, Monica Rinaldi, Lucio Crinò, Cesare Gridelli, Serafino Ricci, Elide Matano, C. Boni, M. Marangolo, Giuseppe Failla, Giuseppe Altavilla, Vincenzo Adamo, A. Ceribelli, M. Clerici, Francesco Di Costanzo, L. Frontini, Maurizio Tonato - Journal of Clinical Oncology 2002 被引用: 891

  21. Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma

    著者: Vittorio Franciosi, Giorgio Cocconi, Maria Michiara, Francesco Di Costanzo, Vinicio Fosser, Maurizio Tonato, Paolo Carlini, C. Boni, Sofia Di Sarra - Cancer 1999 被引用: 240

  22. Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

    著者: Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Lucile Awad, Eric Van Cutsem - Journal of Clinical Oncology 2007 被引用: 182

  23. Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

    著者: Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Cindy Marabotti, Eric Van Cutsem - Journal of Clinical Oncology 2007 被引用: 251

  24. Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen

    著者: Giorgio Cocconi, Mariangela Bella, F. Calabresi, Maurizio Tonato, R Canaletti, C. Boni, Franco Buzzi, Guido Ceci, E. Corgna, Paolo Costa, Renata Lottici, Franco Papadia, Maria Sofra, M. Bacchi - New England Journal of Medicine 1992 被引用: 239